Is Canopy Growth a Smart Cannabis Stock to Own in 2022?

: CGC | Canopy Growth Corporation News, Ratings, and Charts

CGC – Shares of smart cannabis company Canopy Growth (CGC) have retreated in price significantly over the past few months. However, given that the company recently launched new products across its brand portfolio, is it worth betting on the stock now? Read on, let’s find out.

Smith Falls, Canada-based Canopy Growth Corporation (CGC - Get Rating) is a global leader in cannabis and cannabinoid-based consumer products. Recently, the company announced the expansion of its Ace Valley brand portfolio, bringing two new beverage and hard candy forms to market. In addition, last month, it launched the next phase of the Tweed brand with the launch of new products, formats, and a revamp of the brand’s look and feel.

However, the stock has plunged 79.2% in price over the past year and 39.2% over the past three months to close yesterday’s trading session at $8.75. It is currently trading 78.7% below its 52-week high of $41.15.

Furthermore, in December, CGC agreed to divest its subsidiary company, C3 Cannabinoid Compound Company GmbH, to Dermapharm Holding SE, a European pharmaceutical company. The move is intended to further CGC’s transformation into a CPG-style company. However, it may have a negative impact on revenue.

Here is what could shape CGC’s performance in the near term:

Inadequate Financials

CGC’s revenue decreased 8.8% year-over-year to $155.02 million for the third quarter, ended Dec. 31, 2021. Its operating loss came in at $149.96 million. The company reported a $108.93 million net loss of, while its loss per share amounted to $0.28. In addition, its net cash used in operating activities came in at $419.13 million, representing a 13.9% increase for the nine months ended Dec. 31, 2021.

Weak Profitability

CGC’s 0.09% trailing-12-months asset turnover ratio is 74.2% lower than the 0.34% industry average. Also, its ROA, gross profit, and net income margins are negative 6.8%, 4.3%, and 76.8%, respectively. Furthermore, its trailing-12-month cash from operations stood at a negative $408.81 million.

POWR Ratings Reflect Uncertainty

CGC has an overall F rating, which equates to a Strong Sell in our proprietary POWR Ratings system. The POWR ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.

Our proprietary rating system also evaluates each stock based on eight distinct categories. CGC has a D grade for Quality and Stability. The company’s weak financials and poor profitability are consistent with the Quality grade. In addition, the stock beta of 1.93 is in sync with the Stability grade.

Of the 180 stocks in the F-rated Medical – Pharmaceuticals industry, CGC is ranked #175.

Beyond what I have stated above, you can view CGC ratings for Value, Growth, Sentiment, and Momentum here.

Bottom Line

Despite CGC’s recent advancements, the company faces intense competition in the cannabis market. In addition, analysts expect its EPS to decline 128.8% in the next quarter (ending June 2022) and remain negative. Furthermore, given the company’s weak profit margin, we think the stock is best avoided now.

How Does Canopy Growth Corporation (CGC) Stack Up Against its Peers?

While CGC has an overall F rating, one might want to consider its industry peers, Merck & Co. Inc. (MRK - Get Rating), Johnson & Johnson (JNJ - Get Rating), and Novartis AG (NVS - Get Rating), which have an overall A (Strong Buy) rating.

Click here to checkout our Healthcare Sector Report for 2022

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


CGC shares were trading at $8.65 per share on Thursday morning, down $0.10 (-1.14%). Year-to-date, CGC has declined -0.92%, versus a -6.69% rise in the benchmark S&P 500 index during the same period.


About the Author: Pragya Pandey


Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CGCGet RatingGet RatingGet Rating
MRKGet RatingGet RatingGet Rating
JNJGet RatingGet RatingGet Rating
NVSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Investors Remain “Cautiously Optimistic”

The S&P 500 (SPY) has made great advances since the lows of early April. Yet seem to be stuck under resistance at 6,000. What happens next depends on tariff talks. So let’s talk about the latest news on that front.

Bull Market Til Proven Otherwise

The phrase that paid for investors in 2025 was “Bull market til proven otherwise” Steve Reitmeister explains why in his latest market update and preview of top stock picks.

Investor Alert: Mission Accomplished?

The S&P 500 (SPY) has broken out above the 200 day moving average. Does that mean that bear market fears are now over? And should investors be riding the bull to new heights? Read on for Steve Reitmeister’s answer...

Stock Market Update: It’s Complicated!

The S&P 500 (SPY) may have bounced 17% from recent lows, but the outlook for stocks from here is...in a word...COMPLICATED. Read on to get Steve Reitmeister full market outlook and trading plan for this complicated market environment.

Becoming More Bullish on Stocks, But...

Stocks are on a roll with the S&P 500 (SPY) up more than 10% from the recent lows. Before you start getting too giddy, you should read this updated market outlook and trading plan Steve Reitmeister.

Read More Stories

More Canopy Growth Corporation (CGC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CGC News